General Information of the Compound
| Compound ID |
CP0040161
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyran-4-one
Show/Hide
|
||||||||||||||||||
| Synonyms |
2',3,4',5,7-Pentahydroxyflavone
2',4',3,5,7-Pentahydroxyflavone
2',4',5,7-Tetrahydroxyflavan-3-ol
2'-Hydroxypelargidenolon 1522
2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one
3,5,7,2',4'-Pentahydroxyflavone
3,5,7,2',4'-Pentahydroxyflavonol
480-16-0
Al-Morin
Aurantica
Bois d'arc
Bois d'arc [French]
Bois d,Arc
C.I. 75660
C.I. Natural Yellow 11
C.I. Natural Yellow 8
Calico Yellow
MORIN
Morin hydrate
Osage Orange
Osage Orange Crystals
Osage Orange Extract
Toxylon Pomiferum
Zlut prirodni 11
morin
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H10O7
|
||||||||||||||||||
| Molecular Weight |
302.238
|
||||||||||||||||||
| Canonical SMILES |
Oc1ccc(c(O)c1)-c1oc2cc(O)cc(O)c2c(=O)c1O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H10O7/c16-6-1-2-8(9(18)3-6)15-14(21)13(20)12-10(19)4-7(17)5-11(12)22-15/h1-5,16-19,21H
Show/Hide
|
||||||||||||||||||
| InChIKey |
YXOLAZRVSSWPPT-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
11128-85-1
480-16-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01279, Adenosine receptor A3
Protein ID: PT01020, Beta-secretase 1
Protein ID: PT02718, Broad substrate specificity ATP-binding cassette transporter ABCG2
Protein ID: PT03308, G-protein coupled receptor 35
Clinical Information about the Compound
Drug 1 ( MORIN )
| Drug Name | MORIN | ||
|---|---|---|---|
| Target(s) | |||